SUBSCRIBE

Breaking News on Supplements & Nutrition - EuropeUS edition

On your radar > Financial plays

Financial plays

Financial plays

Digging below the bottom lines of ingredients suppliers and brand behemoths. From the impact of the ongoing economic slowdown to the latest in merger and acquisition activity.

Meso-zeaxanthin is pharma and needs holistic research beyond eye health, says expert

The meso-zeaxanthin cartenoid is a synthetic, quasi pharmaceutical that needs holistic research on whole body affects, says an eye health researcher.

You talkin’ to me? The grey zone around health claims in ‘commercial communication’

How we define ‘commercial communication’ when it comes to health claims remains somewhat of a grey zone, according to a Leatherhead analyst.

DISPATCHES FROM VITAFOODS EUROPE 2014

Emotional brain food for madam, and the caffeine source for you sir

When it comes to cognitive health products, women look for emotional ‘brain food’, while men look for caffeine sources, according to a survey of German students.

DISPATCHES FROM VITAFOODS EUROPE 2014

Meso-zeaxanthin’s road to EU novel approval – blindsided by commercial interests?

The discourse around eye health carotenoid meso-zeaxanthin (MZ) has been marred by commercial interests, according to supplement firm OmniActive Health Technologies.

DISPATCHES FROM VITAFOODS Europe 2014

Sustainability? Not so focal for supplements, says palm oil firm

Sustainability is not such an important issue for the supplements industry, because of the relatively low ingredient volumes involved and a difference in industry priorities, Malaysia-based Carotech has said.

Retail positioning sports nutrition's big challenge

Establishing broad acceptance is the greatest challenge facing the sports nutrition segment today, and this hinges on the creation of local mainstream retail channels, according to one analyst. 

BASF Nutrition to hone omega-3, sell Norwegian factory and cut 260 jobs

BASF says it is honing in on its omega-3 business but will sell a recently acquired low-concentration omega-3 facility in Norway as it aims high-end.

UK FSA: "We are working to clear the backlog as quickly as possible."

UK FSA reopens novel foods doors after industry concern

The UK Food Standards Agency (FSA) has backtracked on a decision to close its doors on EU novel foods applications after stakeholder unrest at the UK government austerity driven measure. ...

UK FSA: "If you are interested in submitting a novel food dossier to the EU, we advise you to contact another EU member state..."

UK FSA closes door on novel food applications as austerity bites

The UK Food Standards Agency is no longer accepting novel food applications, a development one public policy expert says is “alarming”.

Meso-zeaxanthin safety & QC debated

Neither illegal, unnatural nor unsafe, says meso-zeaxanthin defender

Meso-zeaxanthin (MZ) proponent says a French government report on the fraudulent use of meso-zeaxanthin in eye health supplements casts unnecessary doubt on a safe and viable compound. ...

Symrise wins battle for Diana Group with €1.3bn bid

German flavours and aromas specialist Symrise has won the battle for French flavour and ingredients producer Diana, after agreeing a deal that values the firm at €1.3bn.

Lost in translation: Parlez-vous health claims?

Cross-border communication must be provided to combat the confusion caused by the 24 subtly different language versions of EU-approved health claims, as well as countless other cultural nuances, according to...

News in brief

DSM in negotiations to buy Chinese vitamin C manufacturer

DSM has ended speculation about acquiring Chinese vitamin C supplier Aland by acknowledging it is in talks with the firm, but asserts no deal has been signed.

US investment network targets European health & wellness firms

Nutrition Capital Network (NCN) is setting up shop in Europe this May at Vitafoods in Geneva and is scouting for investment opportunities in the health and wellness sector.

Russia-Ukraine instability means Kazakhstan leads supplement growth

Russia may still hold the lion share of the dietary supplements market in the Commonwealth of Independent States (CIS), but it’s the comparatively more stable Kazakhstan that will lead in...

BioGaia confirms extended agreement with Nestlé for clinical research and NPD

Swedish probiotic player BioGaia has broadened and strengthened its ties with food manufacturing giant Nestlé by agreeing a deal for clinical research and new product development (NPD), according to the...

Ingredia acquires bioactive peptides startup

French supplier Ingredia has announced its acquisition of bioactive peptides specialist Galactis Pharma.

Indena sees potential in Romania and Moldova

Romania and Moldova may still be small markets, but Indena says it sees in them what it saw in Poland 20 years ago.

Sanofi to contest rebuffed sterol cholesterol claim, but it's no big deal

Sanofi-Aventis has said the European Food Safety Authority’s (EFSA) rejection of its application to broaden the already approved sterol-stanols cholesterol lowering claim to powdered supplements won’t affect the company commercially, but...

BASF nutrition and health jumps 7% to crack €2bn in 2013

‘Nutrition and Health’ was the best performing section within BASF’s ‘Performance Products’ division in 2013, posting a 7% gain on 2012 to push through €2bn in sales for the year.

News in brief

Raisio grows earnings by 14%

Plant-based nutrition firm Raisio has reported record earnings before interest and taxes (EBIT) of almost €40m in 2013.

Emerging markets drive probiotic expansion for Swedish player

A focus on emerging markets has paid off for Swedish probiotics supplier BioGaia with sales and profits up in 2013.

Infographic

Protein still sports nutrition king, but watch out

Protein is still the bedrock of sports nutrition says Euromonitor, but non-protein products are expected to grow faster in several important global markets like Australia, Canada and Indonesia.

Symrise bids for Swedish probiotic player

Symrise has given Swedish probiotic player, Probi’s board and shareholder’s about a month to sell it the remaining 70% it doesn’t own after making a formal bid today.

News in brief

Mérieux NutriSciences strengthens Latin American presence

Mérieux NutriSciences has acquired a Brazilian lab to expand business in Latin America.